Bristol-Myers Squibb Company
(BMY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | GILD | GSK | ||
| Company | Bristol-Myers Squibb Company | Gilead Sciences Inc | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 60.11 | 151.89 | 58.87 | ||
| High | 60.95 | 156.95 | 59.17 | ||
| Low | 60.02 | 151.46 | 58.56 | ||
| Latest | 60.74 | 154.98 | 58.93 | ||
| Change | +0.88 | +3.17 | +0.39 | ||
| % Change | +1.47% | +2.09% | +0.67% | ||
| Volume | 10,819,600 | 6,861,900 | 6,280,800 | ||
| 20-Day Average Volume | 13,678,050 | 8,929,340 | 6,919,950 | ||
| Previous Close | 59.86 | 151.81 | 58.54 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.04 | 142.05 | 53.57 | ||
| 20-Day Raw Stochastic | 84.60% | 93.44% | 88.71% | ||
| 20-Day Relative Strength | 66.20 | 69.29 | 72.33 | ||
| Weighted Alpha | +24.36 | +59.72 | +74.33 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.02% since 02/06/26 | +1.63% since 02/06/26 | -2.16% since 02/06/26 | ||
| Low | 59.25 on 02/12/26 | 147.07 on 02/10/26 | 58.01 on 02/11/26 | ||
| High | 61.63 on 02/09/26 | 157.29 on 02/11/26 | 59.94 on 02/09/26 | ||
| 1-Month | |||||
| %Chg | +8.62% since 01/13/26 | +27.28% since 01/13/26 | +18.10% since 01/13/26 | ||
| Low | 53.54 on 01/21/26 | 120.94 on 01/15/26 | 47.62 on 01/20/26 | ||
| High | 62.05 on 02/06/26 | 157.29 on 02/11/26 | 60.37 on 02/06/26 | ||
| 3-Month | |||||
| %Chg | +24.90% since 11/13/25 | +23.79% since 11/13/25 | +22.41% since 11/13/25 | ||
| Low | 45.26 on 11/20/25 | 116.88 on 01/05/26 | 45.81 on 11/20/25 | ||
| High | 62.05 on 02/06/26 | 157.29 on 02/11/26 | 60.37 on 02/06/26 | ||
| 6-Month | |||||
| %Chg | +26.94% since 08/13/25 | +29.00% since 08/13/25 | +50.60% since 08/13/25 | ||
| Low | 42.52 on 10/29/25 | 108.46 on 10/02/25 | 38.63 on 09/02/25 | ||
| High | 62.05 on 02/06/26 | 157.29 on 02/11/26 | 60.37 on 02/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 121,860,176 | 188,347,648 | 119,328,288 | ||
| Shares Outstanding, K | 2,035,753 | 1,240,680 | 2,038,406 | ||
| Annual Sales | 48,194,000,000 | 28,754,000,000 | 43,077,970,000 | ||
| Annual Net Income | 7,054,000,000 | 480,000,000 | 7,537,690,000 | ||
| Last Quarter Sales | 12,502,000,000 | 7,769,000,000 | 11,464,090,000 | ||
| Last Quarter Net Income | 1,087,000,000 | 3,052,000,000 | 846,040,000 | ||
| 60-Month Beta | 0.29 | 0.36 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.26 on 02/05/26 | 1.86 on 02/10/26 | 0.26 on 02/04/26 | ||
| Latest Earnings Date | 04/23/26 | 04/23/26 | 04/29/26 | ||
| Most Recent Dividend | 0.630 on 01/02/26 | 0.790 on 12/15/25 | 0.426 on 11/14/25 | ||
| Next Ex-Dividends Date | 01/02/26 | 03/13/26 | 02/20/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 9.74 | 19.12 | 12.94 | ||